Monsanto has recently been on the wrong end of several major jury verdicts in lawsuits relating to its product Roundup. Plaintiffs have filed suit against the company, alleging that the weed killer was responsible for cases of non-Hodgkin’s lymphoma. Last year, a terminally ill California man was awarded $ 289 million by a California jury. This was followed by other large verdicts, as juries have reacted viscerally to evidence of Monsanto’s corporate behavior. Now, the company faces many other lawsuits while simultaneously appealing the jury verdicts with which it was already hit.
Roundup has been used as a pesticide for many years, starting with its introduction in 1974. The product was viewed to be a safer alternative to the pesticide DDT. However, there were reports starting in the early part of this century that the product could cause cancer. By 2015, the World Health Organization concluded that glyphosate-based products were “probably carcinogenic to humans.” Nonetheless, the EPA continues to cling to the belief that glyphosate is entirely safe and will not take steps to regulate sales of the product. The regulatory agency will not entertain the mounting evidence to the contrary in reevaluating its opinion.
The first lawsuits began to go in front of juries within the past couple of years. The watershed case was heard in California. The plaintiff was a man named Dewayne Johnson who was terminally ill with cancer. Johnson was a groundskeeper for the school district and had used Roundup for years. Now he had non-Hodgkin’s lymphoma. Of particular interest to the jury was Monsanto’s record of corporate behavior. Rather than objectively assess whether its product was safe, the company attempted to place a finger on the scale by influencing the scientific debate over the possible danger associated with Roundup.